Navigation Links
diaDexus, Inc. Reports 2010 Third Quarter Financial Results
Date:11/15/2010

6619,059,144DIADEXUS, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(In thousands, except share data)September 30,
2010December 31,
2009(unaudited)AssetsCurrent assets:Cash and cash equivalents$

23,238$

2,539Short-term investment securities—2,262Accounts receivable 1,2651,637Receivable from related party196295Inventories106221Restricted cash400—Assets held for sale310—Prepaid expenses and other current assets1,155618Total current assets26,6707,572Restricted cash1,400400Property and equipment, net7841,366Other long-term assets3130Total assets$

28,857$

9,468Liabilities, Convertible Preferred Stock and Stockholders' Equity (Deficit)Current liabilities:Accounts payable$

736$

273Notes payable—3,498Deferred revenues, current portion344318Deferred rent, current portion156194Unfavorable lease obligations383—Accrued and other current liabilities1,7471,922Total current liabilities3,3666,205Long-term deferred rent—103Non-current portion of unfavorable lease obligation3,649—Non-current portion of deferred revenue9121,140Warrant liability—36Other long term liabilities1,058—Total liabilities8,9857,484Commitments and contingenciesConvertible preferred stock—168,242Stockholders' equity (deficit):Common stock53118Additional paid-in capital204,71412,739Accumulated deficit (185,373)(179,015)Total stockholders' equity (deficit)19,872(166,258)Total liabilities, convertible preferred stock and stockholders' equity (deficit)$

28,857$

9,468*

The balance sheet at December 31, 2009 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.
'/>"/>

SOURCE diaDexus, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. diaDexus, Inc. Adds Two New Directors; Corporate Overview & 3Q Results Webcast Set for November 16, 2010
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Spherix Reports Second Quarter Earnings
4. Tapestry Reports Second Quarter 2007 Results
5. Callisto Reports on Second-Quarter 2007 Milestones
6. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
9. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
10. Biopure Reports on Meeting with the FDA
11. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... privately held medical device company, announced today that it ... Corporation (Tokyo Stock Exchange TYO: 8001) to sell its ... in Japan . ViewRay,s technology, the ... MRI-guided radiation therapy system that images and treats cancer ...
(Date:1/22/2015)... 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or ... Omega-3 therapies for cardiovascular disease and overall health is pleased ... in 2014 and its outlook for 2015 from the CEO, ... We would like to take this opportunity to ...
(Date:1/22/2015)... 22, 2015 Increasing sophistication among enterprise buyers of ... purchasing in 2015, says Moravia CMO, ... study by market research firm Common Sense Advisory, 15 ... their translation and localization needs. "From a language industry ...
Breaking Medicine Technology:ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2
... address remaining questions on Marketing ... Authorization Application, ... ) today announced that the Company recently presented to the,Committee ... the European Medicines Evaluation Agency (EMEA), regarding the,Marketing Authorization Application ...
... Infusional Chemotherapy ... -, NUTLEY, N.J., Jan. 24 Roche announced today ... have been,accepted for presentation at the 2008 Gastrointestinal Cancers Symposium ... presentations based on U.S. data offer additional knowledge,about Xeloda. Two ...
Cached Medicine Technology:IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival 2IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival 3IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival 4IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival 5Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium 2Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium 3
(Date:1/22/2015)... 2015 Carinsurancesavings.biz has released a new blog ... dismemberment insurance . , Purchasing an accidental death and ... advantageous. This type of rider provides benefits if the insured ... considered a lesser form of life insurance. , AD&D ...
(Date:1/22/2015)... 2015 Yesterday, Senator Holly Mitchell ... Kristin Olsen (R-Modesto) were honored by the California ... biotechnology, biomedical science, medical device and pharmaceutical innovation ... the “2014 Life Sciences Champion” award from CHI ...
(Date:1/22/2015)... Four years since the release of their debut recording ... marriage of Avasa & Matthew Love – the duo are pleased ... release through White Swan Records on February 24, 2015. , THE ... path available to all of us to walk out of the ...
(Date:1/22/2015)... 2015 As interest in the value of ... momentum worldwide, Rev. Eric J. Hall , president and ... (HCCN), will be the keynote speaker on January 27 at ... health system. , The conference, “Hope and Resilience: Innovative and ...
(Date:1/22/2015)... has released a new blog post explaining the importance of keeping ... costs of an auto insurance policy . , Clients who ... for their vehicle insurance policies. The safety a vehicle offers from ... Because of this, drivers should always carry a first aid kit ...
Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... , , ST. PAUL, Minn., ... microscopic particle pollution like smoke and smog, as well as ... these airborne contaminants to experience shortness of breath, wheezing and ... irritation(1). According to AIRNow.gov(2), a government-developed index for reporting daily ...
... is providing valuable new clues into cancer,s deadliest behavior -- ... spreading throughout the body. Duke University biologist David ... of a single cell in the developing body of a ... one of its jobs is to connect the developing animal,s ...
... MP3 device -- just about every man, woman and child on the ... music, of the primal place it holds in the human imagination. ... the soul -- a frill that has to go when school budgets ... study shows that musicians -- trained to hear sounds embedded in a ...
... , Congressman Chaka Fattah (D-PA) releases the following statement on ... , WASHINGTON, Aug. 17 "We must not let the ... to take place it must include a public option. , ... they deliberate how they will get to their destination. Faced with a ...
... , , NEWINGTON, N.H. Aug. ... and hassle-free atmosphere have struck a chord with consumers, is being ... the fastest-growing private companies in America. , , ... Fitness finished number 471 on the lnc. 500, which ranks the ...
... , CHICAGO, Aug. 17 Presidential Towers, ... two bedroom apartment to the University of Illinois Medical Center (UIMC), ... care at the medical center. , , "Based ... felt that this was a great way to give back to ...
Cached Medicine News:Health News:Bad Air Day Alert: Outdoor Air Pollutants at High Level 2Health News:Bad Air Day Alert: Outdoor Air Pollutants at High Level 3Health News:Cancer's break-in tools possibly identified at Duke 2Health News:Taking up music so you can hear 2Health News:Taking up music so you can hear 3Health News:Planet Fitness Soars to Inc. 500 2Health News:Presidential Towers Donates Apartment to the University of Illinois Medical Center 2
Streck Cytometry Sheath fluid is a ready-to-use, balanced isotonic solution for use on flow cytometers. It is packaged in a 20 liter Cubitainer, and offers a two-year shelf life....
Streck-T-Pack is specially designed for use on Coulter® Counter T Series instruments. Each convenient pack includes diluent, lysing agent and enzymatic cleanser. The shelf life is 18 months from ...
Streck-ONYX-Pack is specially designed for use on Coulter® ONYX Series instruments. Each pack contains diluent and lysing agent. The shelf life is one year from date of manufacture....
... A lytic reagent ... quantitative determination of hemoglobin ... Streck-Lysing Agent IIIA is ... on the Abbott CELL-DYN® ...
Medicine Products: